2021-05-19 09:18 ADCC-Enhanced anti-Citrullinated Peptide is a non-fucosylated therapeutic biobetter antibody engineered by Creative Biolabs' Afuco™ technology platform. By reducing the fucosylation of the Fc region, the ADCC-enhanced antibody shows an increased binding affinity for the FcyR receptor on immune effector cells.
Вы можете показать это желание на своем сайте, в блоге, в форуме и т.д., скопировав и вставив туда этот HTML-код.
